000 01636 a2200433 4500
005 20250515121425.0
264 0 _c20080911
008 200809s 0 0 eng d
022 _a0271-0749
024 7 _a10.1097/JCP.0b013e318173083e
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFriedel, Robert O
245 0 0 _aRisperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cJun 2008
300 _a345-7 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBorderline Personality Disorder
_xdiagnosis
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOutcome Assessment, Health Care
_xstatistics & numerical data
650 0 4 _aPersonality Inventory
_xstatistics & numerical data
650 0 4 _aPilot Projects
650 0 4 _aPsychometrics
650 0 4 _aQuality of Life
650 0 4 _aRisperidone
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aJackson, Warren T
700 1 _aHuston, Celia S
700 1 _aMay, Roberta S
700 1 _aKirby, Nancy L
700 1 _aStoves, Andrée
773 0 _tJournal of clinical psychopharmacology
_gvol. 28
_gno. 3
_gp. 345-7
856 4 0 _uhttps://doi.org/10.1097/JCP.0b013e318173083e
_zAvailable from publisher's website
999 _c17975374
_d17975374